RE:RE:RE:RE:RE:RE:RE:RE:RE:Bayer deal todayI understand that there is trial and error involved in Ph 1b , the process has to be tweaked . The fact remains that TLT has enough data pre clinical and clinical to present a strong case . There is precedence of biotechs signing good financial deals before Ph 2 and i think that my employee ,RW , can do it . When i hire a carpenter , i don't watch over him constantly ...i expect the job to be done properly without too many errors because he's the expert . RW , for the moment , is my expert . If he does another PP that will be one unforgivable error . The present valuation of TLT could be considered a crime orchestraded by the manipulators . Mr. Dumoulin-White you're an intelligent man ....find a way to protect your shareholders and maximize our ROI .
GO TLT GO
GO RW GO
GLTA